Benzingaยท2025-11-17 13:15Core Insights - Two stocks in the health care sector are showing signs of being overbought, which may concern momentum-focused investors [1][2] Company Summaries - Avadel Pharmaceuticals PLC (NASDAQ:AVDL): Received an unsolicited acquisition proposal from Lundbeck valuing the company at up to $23 per share, consisting of $21 in cash and up to $2 in contingent value rights (CVR) milestones. The stock has increased approximately 55% over the past month, reaching a 52-week high of $23.57. The RSI value is at 95.1, indicating strong momentum. On the last trading day, shares rose 22.5% to close at $23.56 [7] - Cidara Therapeutics Inc (NASDAQ:CDTX): Merck & Co. Inc. has agreed to acquire Cidara for $221.50 per share in cash, totaling around $9.2 billion. The stock has surged about 114% over the past month, with a 52-week high of $218.85. The RSI value stands at 93.7, reflecting significant momentum. On the last trading day, shares increased by 105.4% to close at $217.71 [7]